EFFECT OF RANDOMIZED WITHDRAWAL OF BUDESONIDE ORAL SUSPENSION ON EFFICACY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS OF HISTOLOGIC, SYMPTOM AND ENDOSCOPIC OUTCOMES

被引:0
|
作者
Dellon, Evan S.
Collins, Margaret H.
Katzka, David A.
Mukkada, Vincent A.
Falk, Gary W.
Goodwin, Bridgett
Terreri, Brian
Zhang, Wenwen
Boules, Mena
Desai, Nirav K.
Hirano, Ikuo
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
990
引用
收藏
页码:S238 / S238
页数:1
相关论文
共 50 条
  • [31] Efficacy And Safety Of Budesonide Oral Suspension In A Pediatric Population: Pooled Data From A Phase 2 And Phase 3 Trial In Patients With Eosinophilic Esophagitis
    Gupta, Sandeep
    Mukkada, Vincent
    Dellon, Evan
    Gold, Benjamin
    Collins, Margaret
    Katzka, David
    Falk, Gary
    Lan, Lan
    Desai, Nirav
    Williams, James
    Hirano, Ikuo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB91 - AB91
  • [32] Efficacy of Topical Corticosteroids in Achieving Histologic, Clinical, and Endoscopic Remission in Patients With Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Chehade, Nabil El Hage
    Chahine, Anastasia
    Ghoneim, Sara
    Chehade, Nour El Hage
    Davila, Josue
    Saleh, Sherif
    Shibli, Fahmi
    Fass, Ronnie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S159 - S159
  • [33] Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial (vol 20, pg 525, 2022)
    Liu, Wanqing
    Chen, Peng
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) : 2418 - 2418
  • [34] Reduction of Esophageal Epithelial Pathology and Endoscopic Abnormalities Following Treatment With Oral Budesonide Suspension (OBS) in Pediatric Subjects With Eosinophilic Esophagitis (EoE)
    Collins, Margaret H.
    Irani, Anne-Marie
    Ngo, Peter D.
    Vitanza, Joanne M.
    GASTROENTEROLOGY, 2011, 140 (05) : S237 - S237
  • [35] PREDICTORS OF RESPONSE TO CORTICOSTEROID THERAPY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION
    Hirano, Ikuo
    Katzka, David A.
    Collins, Margaret H.
    Mukkada, Vincent A.
    Gold, Benjamin D.
    Falk, Gary W.
    Williams, James
    Desai, Nirav K.
    Lan, Lan
    Dellon, Evan S.
    GASTROENTEROLOGY, 2020, 158 (06) : S817 - S818
  • [36] Improved Histopathologic Features in Patients With Eosinophilic Esophagitis: Results and Analyses From a Phase 3, Randomized, Placebo-Controlled Trial of Budesonide Oral Suspension
    Collins, Margaret H.
    Hirano, Ikuo
    Katzka, David A.
    Mukkada, Vincent A.
    Falk, Gary W.
    Williams, James E.
    Desai, Nirav K.
    Lan, Lan
    Dellon, Evan S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S200 - S201
  • [37] A META-ANALYSIS OF EFFICACY OF TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS: FROM THE PERSPECTIVE OF HISTOLOGIC, CLINICAL, AND ENDOSCOPIC OUTCOME
    Hao, Lixiao
    Lu, Yi
    Li, Tao
    GUT, 2020, 69 : A28 - A29
  • [38] A meta-analysis of efficacy of topical steroids in eosinophilic esophagitis: From the perspective of histologic, clinical, and endoscopic outcome
    Hao, Li-Xiao
    Lu, Yi
    Li, Tao
    Gong, Biao
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (04): : 251 - 260
  • [39] Safety and Efficacy of Oral Budesonide Suspension for Maintenance Therapy in Eosinophilic Esophagitis: Results From a Prospective Open-Label Study of Adolescents and Adults
    Dellon, Evan
    Katzka, David A.
    Collins, Margaret H.
    Hamdani, Mohamed
    Gupta, Sandeep K.
    Hirano, Ikuo
    GASTROENTEROLOGY, 2016, 150 (04) : S188 - S188
  • [40] Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies
    Prashanth Rawla
    Tagore Sunkara
    Krishna Chaitanya Thandra
    Vinaya Gaduputi
    Drugs in R&D, 2018, 18 : 259 - 269